Part B drugs – Talk Bio

Actionable Insights Powered by AI

CMS Selects Trulicity and Biktarvy Among 15 Drugs for Third Medicare Price Negotiation Cycle

CMS; Medicare negotiations; Trulicity; Biktarvy; drug pricing; Part B drugs; Trump administration